癌症需紧急性腺毒性治疗女性在月经周期不同阶段行未成熟卵母细胞取卵与体外成熟
回顾性队列研究纳入164名癌症需紧急化疗女性,共192个周期,按取卵时月经周期阶段分早卵泡期、晚卵泡期和黄体期。各阶段获卵数、48小时成熟率、冷冻卵母细胞数、受精率及冷冻胚胎数均无统计学显著差异,结论支持任何阶段均可进行IVM取卵。
要点
- 早卵泡期、晚卵泡期和黄体期取卵的获卵数、成熟率及冷冻卵母细胞数均无统计学显著差异。
- 各阶段受精率和冷冻胚胎数同样无统计学显著差异。
- 作者认为IVM是化疗不能延迟或卵巢刺激禁忌时的替代方法,长期结局有待研究。
核心结论
- 本研究证实月经周期任何阶段进行IVM取卵均可行。
- 当化疗不能延迟或卵巢刺激禁忌时,IVM治疗是一种替代方法。
- 长期结局仍有待研究。
研究设计与样本
- 回顾性队列研究,在大学教学医院进行。
- 纳入164名因癌症需紧急化疗而接受IVM治疗以保留生育力的女性。
- 共分析192个周期,分为早卵泡期(n=46)、晚卵泡期(n=107)和黄体期(n=39)。
- 干预包括取卵、IVM和冷冻保存。
主要发现
- 获卵数中位数(四分位距)在早卵泡期、晚卵泡期和黄体期分别为8.5(4-15.8)、8(5-14)和7(4-9),无统计学显著差异。
- 48小时培养后成熟率分别为53.5%(39.8-77)、58%(44-82)和50%(33-67),无统计学显著差异。
- 冷冻卵母细胞数分别为3(0-7.3)、3(0-7)和3(1-5.5),无统计学显著差异。
- 受精率分别为77%(62.8-92.5)、75%(60-100)和63.5%(50-75),无统计学显著差异。
- 冷冻胚胎数分别为3(2-5.8)、3(0.5-5)和2(1-3),无统计学显著差异。
临床怎么用
- 作者认为IVM是化疗不能延迟或卵巢刺激禁忌时可考虑的替代方法。
- 原文未据此给出其他推荐。
局限性
- 长期结局仍有待研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the feasibility and the efficacy of in vitro maturation (IVM) when immature oocyte collection was performed in the early follicular, late follicular, or luteal phases in women with cancer who require urgent chemotherapy. DESIGN: Retrospective cohort study. SETTING: University teaching hospital. PATIENT(S): One-hundred and sixty-four women with cancer undergoing IVM treatment for fertility preservation. INTERVENTION(S): Oocyte retrieval, IVM, cryopreservation. MAIN OUTCOME MEASURE(S): Medians (interquartile range) of oocytes collected, maturation rates after 48 hours of culture, and metaphase II oocytes cryopreserved. RESULT(S): The analysis included a total of 192 cycles grouped into early follicular phase (n = 46), late follicular phase (n = 107), or luteal phase (n = 39). Embryo cryopreservation was performed in 82 cycles, and oocyte cryopreservation in 105 cycles. Between the early follicular, late follicular, and luteal phases, no statistically significant differences were found in the number of oocytes collected (8.5 [4-15.8], 8 [5-14], and 7 [4-9], respectively), the maturation rates after 48 hours of culture (53.5% [39.8-77], 58% [44-82], and 50% [33-67], respectively), or the number of oocytes cryopreserved (3 [0-7.3], 3 [0-7], and 3 [1-5.5], respectively). Similarly, the fertilization rates (77 [62.8-92.5], 75 [60-100], and 63.5 [50-75], respectively) and number of embryos cryopreserved (3 [2-5.8], 3 [0.5-5], and 2 [1-3], respectively) were not statistically significantly different among the groups. CONCLUSION(S): Our study confirms the feasibility of IVM collection at any time during the menstrual cycle. Treatment with IVM is an alternative method when chemotherapy cannot be delayed or ovarian stimulation is contraindicated. The long-term outcomes remain to be studied.
引用
- Creux H, Monnier P, Son WY, et al. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertil Steril. 2016. PMID: 27810160. doi:10.1016/j.fertnstert.2016.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。